You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Professional Issues Articles
Popular Professional Issues Articles
Highly Recommended Professional Issues Articles
Send a link to this page to your friends and colleagues.
Peripheral neuropathy (limb nerve damage) eventually afflicts fifty percent of people with diabetes; worse still, it leads to an amputation every fifty seconds world-wide. At the moment, nothing is approved in the U.S. to treat peripheral neuropathy, only to alleviate the pain that it causes. That might change soon, however.
A large eight-year study out of the University of Western Australia indicates that statins (like Lipitor) and fibrates (like Lopid and TriCor) can reduce risk of peripheral neuropathy. Of course, statins and fibrates are already being prescribed to lower LDL (bad cholesterol) and protect against heart attack and stroke.
But the Australian researchers found that statins also reduced risk of peripheral neuropathy by 35 percent and fibrates by 48 percent (essentially equivalent numbers in the murky world of statistics).
Even better, the researchers believe that the two classes of drugs may work through different mechanisms, so taking both a fibrate and a statin might have twice the beneficial effect on neuropathy of taking either one alone. How they do the job isn't yet understood, but it is hypothesized that statins, at least, reduce both inflammation and oxidative stress.
* * *
Source: 67th Scientific Sessions of the American Diabetes Association
5 comments - Jul 31, 2007
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.